Global Neuromyelitis Optica Drug Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Neuromyelitis Optica Drug market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Neuromyelitis Optica Drug market are covered in Chapter 9:
Alexion Pharmaceuticals
Chugai Pharmaceutical
Roche Holding AG
Viela Bio
In Chapter 5 and Chapter 7.3, based on types, the Neuromyelitis Optica Drug market from 2017 to 2027 is primarily split into:
Glucocorticoids
Immunotherapies
Other
In Chapter 6 and Chapter 7.4, based on applications, the Neuromyelitis Optica Drug market from 2017 to 2027 covers:
Acute attack
Remission Prophylactic Treatment
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Neuromyelitis Optica Drug market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Neuromyelitis Optica Drug Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 NEUROMYELITIS OPTICA DRUG MARKET OVERVIEW
1.1 Product Overview and Scope of Neuromyelitis Optica Drug Market
1.2 Neuromyelitis Optica Drug Market Segment by Type
1.2.1 Global Neuromyelitis Optica Drug Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Neuromyelitis Optica Drug Market Segment by Application
1.3.1 Neuromyelitis Optica Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Neuromyelitis Optica Drug Market, Region Wise (2017-2027)
1.4.1 Global Neuromyelitis Optica Drug Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.3 Europe Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.4 China Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.5 Japan Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.6 India Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.8 Latin America Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.5 Global Market Size of Neuromyelitis Optica Drug (2017-2027)
1.5.1 Global Neuromyelitis Optica Drug Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Neuromyelitis Optica Drug Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Neuromyelitis Optica Drug Market
2 INDUSTRY OUTLOOK
2.1 Neuromyelitis Optica Drug Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Neuromyelitis Optica Drug Market Drivers Analysis
2.4 Neuromyelitis Optica Drug Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Neuromyelitis Optica Drug Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Neuromyelitis Optica Drug Industry Development
3 GLOBAL NEUROMYELITIS OPTICA DRUG MARKET LANDSCAPE BY PLAYER
3.1 Global Neuromyelitis Optica Drug Sales Volume and Share by Player (2017-2022)
3.2 Global Neuromyelitis Optica Drug Revenue and Market Share by Player (2017-2022)
3.3 Global Neuromyelitis Optica Drug Average Price by Player (2017-2022)
3.4 Global Neuromyelitis Optica Drug Gross Margin by Player (2017-2022)
3.5 Neuromyelitis Optica Drug Market Competitive Situation and Trends
3.5.1 Neuromyelitis Optica Drug Market Concentration Rate
3.5.2 Neuromyelitis Optica Drug Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL NEUROMYELITIS OPTICA DRUG SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Neuromyelitis Optica Drug Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Neuromyelitis Optica Drug Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Neuromyelitis Optica Drug Market Under COVID-19
4.5 Europe Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Neuromyelitis Optica Drug Market Under COVID-19
4.6 China Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Neuromyelitis Optica Drug Market Under COVID-19
4.7 Japan Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Neuromyelitis Optica Drug Market Under COVID-19
4.8 India Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Neuromyelitis Optica Drug Market Under COVID-19
4.9 Southeast Asia Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Neuromyelitis Optica Drug Market Under COVID-19
4.10 Latin America Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Neuromyelitis Optica Drug Market Under COVID-19
4.11 Middle East and Africa Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Neuromyelitis Optica Drug Market Under COVID-19
5 GLOBAL NEUROMYELITIS OPTICA DRUG SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Neuromyelitis Optica Drug Sales Volume and Market Share by Type (2017-2022)
5.2 Global Neuromyelitis Optica Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Neuromyelitis Optica Drug Price by Type (2017-2022)
5.4 Global Neuromyelitis Optica Drug Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Neuromyelitis Optica Drug Sales Volume, Revenue and Growth Rate of Glucocorticoids (2017-2022)
5.4.2 Global Neuromyelitis Optica Drug Sales Volume, Revenue and Growth Rate of Immunotherapies (2017-2022)
5.4.3 Global Neuromyelitis Optica Drug Sales Volume, Revenue and Growth Rate of Other (2017-2022)
6 GLOBAL NEUROMYELITIS OPTICA DRUG MARKET ANALYSIS BY APPLICATION
6.1 Global Neuromyelitis Optica Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Neuromyelitis Optica Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Neuromyelitis Optica Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Neuromyelitis Optica Drug Consumption and Growth Rate of Acute attack (2017-2022)
6.3.2 Global Neuromyelitis Optica Drug Consumption and Growth Rate of Remission Prophylactic Treatment (2017-2022)
7 GLOBAL NEUROMYELITIS OPTICA DRUG MARKET FORECAST (2022-2027)
7.1 Global Neuromyelitis Optica Drug Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Neuromyelitis Optica Drug Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Neuromyelitis Optica Drug Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Neuromyelitis Optica Drug Price and Trend Forecast (2022-2027)
7.2 Global Neuromyelitis Optica Drug Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Neuromyelitis Optica Drug Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Neuromyelitis Optica Drug Revenue and Growth Rate of Glucocorticoids (2022-2027)
7.3.2 Global Neuromyelitis Optica Drug Revenue and Growth Rate of Immunotherapies (2022-2027)
7.3.3 Global Neuromyelitis Optica Drug Revenue and Growth Rate of Other (2022-2027)
7.4 Global Neuromyelitis Optica Drug Consumption Forecast by Application (2022-2027)
7.4.1 Global Neuromyelitis Optica Drug Consumption Value and Growth Rate of Acute attack(2022-2027)
7.4.2 Global Neuromyelitis Optica Drug Consumption Value and Growth Rate of Remission Prophylactic Treatment(2022-2027)
7.5 Neuromyelitis Optica Drug Market Forecast Under COVID-19
8 NEUROMYELITIS OPTICA DRUG MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Neuromyelitis Optica Drug Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Neuromyelitis Optica Drug Analysis
8.6 Major Downstream Buyers of Neuromyelitis Optica Drug Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Neuromyelitis Optica Drug Industry
9 PLAYERS PROFILES
9.1 Alexion Pharmaceuticals
9.1.1 Alexion Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Neuromyelitis Optica Drug Product Profiles, Application and Specification
9.1.3 Alexion Pharmaceuticals Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Chugai Pharmaceutical
9.2.1 Chugai Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Neuromyelitis Optica Drug Product Profiles, Application and Specification
9.2.3 Chugai Pharmaceutical Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Roche Holding AG
9.3.1 Roche Holding AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Neuromyelitis Optica Drug Product Profiles, Application and Specification
9.3.3 Roche Holding AG Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Viela Bio
9.4.1 Viela Bio Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Neuromyelitis Optica Drug Product Profiles, Application and Specification
9.4.3 Viela Bio Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Neuromyelitis Optica Drug Market
1.2 Neuromyelitis Optica Drug Market Segment by Type
1.2.1 Global Neuromyelitis Optica Drug Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Neuromyelitis Optica Drug Market Segment by Application
1.3.1 Neuromyelitis Optica Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Neuromyelitis Optica Drug Market, Region Wise (2017-2027)
1.4.1 Global Neuromyelitis Optica Drug Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.3 Europe Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.4 China Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.5 Japan Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.6 India Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.8 Latin America Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Neuromyelitis Optica Drug Market Status and Prospect (2017-2027)
1.5 Global Market Size of Neuromyelitis Optica Drug (2017-2027)
1.5.1 Global Neuromyelitis Optica Drug Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Neuromyelitis Optica Drug Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Neuromyelitis Optica Drug Market
2 INDUSTRY OUTLOOK
2.1 Neuromyelitis Optica Drug Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Neuromyelitis Optica Drug Market Drivers Analysis
2.4 Neuromyelitis Optica Drug Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Neuromyelitis Optica Drug Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Neuromyelitis Optica Drug Industry Development
3 GLOBAL NEUROMYELITIS OPTICA DRUG MARKET LANDSCAPE BY PLAYER
3.1 Global Neuromyelitis Optica Drug Sales Volume and Share by Player (2017-2022)
3.2 Global Neuromyelitis Optica Drug Revenue and Market Share by Player (2017-2022)
3.3 Global Neuromyelitis Optica Drug Average Price by Player (2017-2022)
3.4 Global Neuromyelitis Optica Drug Gross Margin by Player (2017-2022)
3.5 Neuromyelitis Optica Drug Market Competitive Situation and Trends
3.5.1 Neuromyelitis Optica Drug Market Concentration Rate
3.5.2 Neuromyelitis Optica Drug Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL NEUROMYELITIS OPTICA DRUG SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Neuromyelitis Optica Drug Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Neuromyelitis Optica Drug Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Neuromyelitis Optica Drug Market Under COVID-19
4.5 Europe Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Neuromyelitis Optica Drug Market Under COVID-19
4.6 China Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Neuromyelitis Optica Drug Market Under COVID-19
4.7 Japan Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Neuromyelitis Optica Drug Market Under COVID-19
4.8 India Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Neuromyelitis Optica Drug Market Under COVID-19
4.9 Southeast Asia Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Neuromyelitis Optica Drug Market Under COVID-19
4.10 Latin America Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Neuromyelitis Optica Drug Market Under COVID-19
4.11 Middle East and Africa Neuromyelitis Optica Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Neuromyelitis Optica Drug Market Under COVID-19
5 GLOBAL NEUROMYELITIS OPTICA DRUG SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Neuromyelitis Optica Drug Sales Volume and Market Share by Type (2017-2022)
5.2 Global Neuromyelitis Optica Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Neuromyelitis Optica Drug Price by Type (2017-2022)
5.4 Global Neuromyelitis Optica Drug Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Neuromyelitis Optica Drug Sales Volume, Revenue and Growth Rate of Glucocorticoids (2017-2022)
5.4.2 Global Neuromyelitis Optica Drug Sales Volume, Revenue and Growth Rate of Immunotherapies (2017-2022)
5.4.3 Global Neuromyelitis Optica Drug Sales Volume, Revenue and Growth Rate of Other (2017-2022)
6 GLOBAL NEUROMYELITIS OPTICA DRUG MARKET ANALYSIS BY APPLICATION
6.1 Global Neuromyelitis Optica Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Neuromyelitis Optica Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Neuromyelitis Optica Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Neuromyelitis Optica Drug Consumption and Growth Rate of Acute attack (2017-2022)
6.3.2 Global Neuromyelitis Optica Drug Consumption and Growth Rate of Remission Prophylactic Treatment (2017-2022)
7 GLOBAL NEUROMYELITIS OPTICA DRUG MARKET FORECAST (2022-2027)
7.1 Global Neuromyelitis Optica Drug Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Neuromyelitis Optica Drug Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Neuromyelitis Optica Drug Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Neuromyelitis Optica Drug Price and Trend Forecast (2022-2027)
7.2 Global Neuromyelitis Optica Drug Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Neuromyelitis Optica Drug Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Neuromyelitis Optica Drug Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Neuromyelitis Optica Drug Revenue and Growth Rate of Glucocorticoids (2022-2027)
7.3.2 Global Neuromyelitis Optica Drug Revenue and Growth Rate of Immunotherapies (2022-2027)
7.3.3 Global Neuromyelitis Optica Drug Revenue and Growth Rate of Other (2022-2027)
7.4 Global Neuromyelitis Optica Drug Consumption Forecast by Application (2022-2027)
7.4.1 Global Neuromyelitis Optica Drug Consumption Value and Growth Rate of Acute attack(2022-2027)
7.4.2 Global Neuromyelitis Optica Drug Consumption Value and Growth Rate of Remission Prophylactic Treatment(2022-2027)
7.5 Neuromyelitis Optica Drug Market Forecast Under COVID-19
8 NEUROMYELITIS OPTICA DRUG MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Neuromyelitis Optica Drug Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Neuromyelitis Optica Drug Analysis
8.6 Major Downstream Buyers of Neuromyelitis Optica Drug Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Neuromyelitis Optica Drug Industry
9 PLAYERS PROFILES
9.1 Alexion Pharmaceuticals
9.1.1 Alexion Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Neuromyelitis Optica Drug Product Profiles, Application and Specification
9.1.3 Alexion Pharmaceuticals Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Chugai Pharmaceutical
9.2.1 Chugai Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Neuromyelitis Optica Drug Product Profiles, Application and Specification
9.2.3 Chugai Pharmaceutical Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Roche Holding AG
9.3.1 Roche Holding AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Neuromyelitis Optica Drug Product Profiles, Application and Specification
9.3.3 Roche Holding AG Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Viela Bio
9.4.1 Viela Bio Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Neuromyelitis Optica Drug Product Profiles, Application and Specification
9.4.3 Viela Bio Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Neuromyelitis Optica Drug Product Picture
Table Global Neuromyelitis Optica Drug Market Sales Volume and CAGR (%) Comparison by Type
Table Neuromyelitis Optica Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Neuromyelitis Optica Drug Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Neuromyelitis Optica Drug Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Neuromyelitis Optica Drug Industry Development
Table Global Neuromyelitis Optica Drug Sales Volume by Player (2017-2022)
Table Global Neuromyelitis Optica Drug Sales Volume Share by Player (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume Share by Player in 2021
Table Neuromyelitis Optica Drug Revenue (Million USD) by Player (2017-2022)
Table Neuromyelitis Optica Drug Revenue Market Share by Player (2017-2022)
Table Neuromyelitis Optica Drug Price by Player (2017-2022)
Table Neuromyelitis Optica Drug Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Neuromyelitis Optica Drug Sales Volume, Region Wise (2017-2022)
Table Global Neuromyelitis Optica Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume Market Share, Region Wise in 2021
Table Global Neuromyelitis Optica Drug Revenue (Million USD), Region Wise (2017-2022)
Table Global Neuromyelitis Optica Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Neuromyelitis Optica Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Neuromyelitis Optica Drug Revenue Market Share, Region Wise in 2021
Table Global Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Neuromyelitis Optica Drug Sales Volume by Type (2017-2022)
Table Global Neuromyelitis Optica Drug Sales Volume Market Share by Type (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume Market Share by Type in 2021
Table Global Neuromyelitis Optica Drug Revenue (Million USD) by Type (2017-2022)
Table Global Neuromyelitis Optica Drug Revenue Market Share by Type (2017-2022)
Figure Global Neuromyelitis Optica Drug Revenue Market Share by Type in 2021
Table Neuromyelitis Optica Drug Price by Type (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume and Growth Rate of Glucocorticoids (2017-2022)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Glucocorticoids (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume and Growth Rate of Immunotherapies (2017-2022)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Immunotherapies (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume and Growth Rate of Other (2017-2022)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Other (2017-2022)
Table Global Neuromyelitis Optica Drug Consumption by Application (2017-2022)
Table Global Neuromyelitis Optica Drug Consumption Market Share by Application (2017-2022)
Table Global Neuromyelitis Optica Drug Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Neuromyelitis Optica Drug Consumption Revenue Market Share by Application (2017-2022)
Table Global Neuromyelitis Optica Drug Consumption and Growth Rate of Acute attack (2017-2022)
Table Global Neuromyelitis Optica Drug Consumption and Growth Rate of Remission Prophylactic Treatment (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Neuromyelitis Optica Drug Price and Trend Forecast (2022-2027)
Figure USA Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Neuromyelitis Optica Drug Market Sales Volume Forecast, by Type
Table Global Neuromyelitis Optica Drug Sales Volume Market Share Forecast, by Type
Table Global Neuromyelitis Optica Drug Market Revenue (Million USD) Forecast, by Type
Table Global Neuromyelitis Optica Drug Revenue Market Share Forecast, by Type
Table Global Neuromyelitis Optica Drug Price Forecast, by Type
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Glucocorticoids (2022-2027)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Glucocorticoids (2022-2027)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Immunotherapies (2022-2027)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Immunotherapies (2022-2027)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Other (2022-2027)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Other (2022-2027)
Table Global Neuromyelitis Optica Drug Market Consumption Forecast, by Application
Table Global Neuromyelitis Optica Drug Consumption Market Share Forecast, by Application
Table Global Neuromyelitis Optica Drug Market Revenue (Million USD) Forecast, by Application
Table Global Neuromyelitis Optica Drug Revenue Market Share Forecast, by Application
Figure Global Neuromyelitis Optica Drug Consumption Value (Million USD) and Growth Rate of Acute attack (2022-2027)
Figure Global Neuromyelitis Optica Drug Consumption Value (Million USD) and Growth Rate of Remission Prophylactic Treatment (2022-2027)
Figure Neuromyelitis Optica Drug Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Alexion Pharmaceuticals Profile
Table Alexion Pharmaceuticals Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Alexion Pharmaceuticals Neuromyelitis Optica Drug Sales Volume and Growth Rate
Figure Alexion Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Chugai Pharmaceutical Profile
Table Chugai Pharmaceutical Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Chugai Pharmaceutical Neuromyelitis Optica Drug Sales Volume and Growth Rate
Figure Chugai Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Roche Holding AG Profile
Table Roche Holding AG Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche Holding AG Neuromyelitis Optica Drug Sales Volume and Growth Rate
Figure Roche Holding AG Revenue (Million USD) Market Share 2017-2022
Table Viela Bio Profile
Table Viela Bio Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Viela Bio Neuromyelitis Optica Drug Sales Volume and Growth Rate
Figure Viela Bio Revenue (Million USD) Market Share 2017-2022
Figure Neuromyelitis Optica Drug Product Picture
Table Global Neuromyelitis Optica Drug Market Sales Volume and CAGR (%) Comparison by Type
Table Neuromyelitis Optica Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Neuromyelitis Optica Drug Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Neuromyelitis Optica Drug Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Neuromyelitis Optica Drug Industry Development
Table Global Neuromyelitis Optica Drug Sales Volume by Player (2017-2022)
Table Global Neuromyelitis Optica Drug Sales Volume Share by Player (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume Share by Player in 2021
Table Neuromyelitis Optica Drug Revenue (Million USD) by Player (2017-2022)
Table Neuromyelitis Optica Drug Revenue Market Share by Player (2017-2022)
Table Neuromyelitis Optica Drug Price by Player (2017-2022)
Table Neuromyelitis Optica Drug Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Neuromyelitis Optica Drug Sales Volume, Region Wise (2017-2022)
Table Global Neuromyelitis Optica Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume Market Share, Region Wise in 2021
Table Global Neuromyelitis Optica Drug Revenue (Million USD), Region Wise (2017-2022)
Table Global Neuromyelitis Optica Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Neuromyelitis Optica Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Neuromyelitis Optica Drug Revenue Market Share, Region Wise in 2021
Table Global Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Neuromyelitis Optica Drug Sales Volume by Type (2017-2022)
Table Global Neuromyelitis Optica Drug Sales Volume Market Share by Type (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume Market Share by Type in 2021
Table Global Neuromyelitis Optica Drug Revenue (Million USD) by Type (2017-2022)
Table Global Neuromyelitis Optica Drug Revenue Market Share by Type (2017-2022)
Figure Global Neuromyelitis Optica Drug Revenue Market Share by Type in 2021
Table Neuromyelitis Optica Drug Price by Type (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume and Growth Rate of Glucocorticoids (2017-2022)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Glucocorticoids (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume and Growth Rate of Immunotherapies (2017-2022)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Immunotherapies (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume and Growth Rate of Other (2017-2022)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Other (2017-2022)
Table Global Neuromyelitis Optica Drug Consumption by Application (2017-2022)
Table Global Neuromyelitis Optica Drug Consumption Market Share by Application (2017-2022)
Table Global Neuromyelitis Optica Drug Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Neuromyelitis Optica Drug Consumption Revenue Market Share by Application (2017-2022)
Table Global Neuromyelitis Optica Drug Consumption and Growth Rate of Acute attack (2017-2022)
Table Global Neuromyelitis Optica Drug Consumption and Growth Rate of Remission Prophylactic Treatment (2017-2022)
Figure Global Neuromyelitis Optica Drug Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Neuromyelitis Optica Drug Price and Trend Forecast (2022-2027)
Figure USA Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Neuromyelitis Optica Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Neuromyelitis Optica Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Neuromyelitis Optica Drug Market Sales Volume Forecast, by Type
Table Global Neuromyelitis Optica Drug Sales Volume Market Share Forecast, by Type
Table Global Neuromyelitis Optica Drug Market Revenue (Million USD) Forecast, by Type
Table Global Neuromyelitis Optica Drug Revenue Market Share Forecast, by Type
Table Global Neuromyelitis Optica Drug Price Forecast, by Type
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Glucocorticoids (2022-2027)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Glucocorticoids (2022-2027)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Immunotherapies (2022-2027)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Immunotherapies (2022-2027)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Other (2022-2027)
Figure Global Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate of Other (2022-2027)
Table Global Neuromyelitis Optica Drug Market Consumption Forecast, by Application
Table Global Neuromyelitis Optica Drug Consumption Market Share Forecast, by Application
Table Global Neuromyelitis Optica Drug Market Revenue (Million USD) Forecast, by Application
Table Global Neuromyelitis Optica Drug Revenue Market Share Forecast, by Application
Figure Global Neuromyelitis Optica Drug Consumption Value (Million USD) and Growth Rate of Acute attack (2022-2027)
Figure Global Neuromyelitis Optica Drug Consumption Value (Million USD) and Growth Rate of Remission Prophylactic Treatment (2022-2027)
Figure Neuromyelitis Optica Drug Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Alexion Pharmaceuticals Profile
Table Alexion Pharmaceuticals Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Alexion Pharmaceuticals Neuromyelitis Optica Drug Sales Volume and Growth Rate
Figure Alexion Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Chugai Pharmaceutical Profile
Table Chugai Pharmaceutical Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Chugai Pharmaceutical Neuromyelitis Optica Drug Sales Volume and Growth Rate
Figure Chugai Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Roche Holding AG Profile
Table Roche Holding AG Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche Holding AG Neuromyelitis Optica Drug Sales Volume and Growth Rate
Figure Roche Holding AG Revenue (Million USD) Market Share 2017-2022
Table Viela Bio Profile
Table Viela Bio Neuromyelitis Optica Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Viela Bio Neuromyelitis Optica Drug Sales Volume and Growth Rate
Figure Viela Bio Revenue (Million USD) Market Share 2017-2022
